Boston Biotech Execs Job-Hopping Due to Scientific Breakthroughs, Startups Rolling in Cash and Big Pharma Setting Up Shop

CAMBRIDGE — Jose-Carlos Gutierrez-Ramos spent five years leading biotherapeutics research at the drug maker Pfizer Inc. When he wasn’t overseeing dozens of research and development programs, he was often batting away inquiries — more than 50 a year — from professional headhunters trying to lure him to another job.

“In the last 12 months [at Pfizer], I got more than 100 calls,” he recalled. “They call if they hear there’s a change in your work environment. Or they just call out of the blue. If they hear that you’re in the market, it’s not unusual to have six or seven offers.”
MORE ON THIS TOPIC